glp-1 and kidney disease Frontiers The privileged position of glp-1

Thyroid follicular cells in HT patients can aberrantly express both B7.1 and MHC class II molecules, enabling them to function as non-professional APCs and directly participate in autoimmune activation

The tirzepatide dosing schedule involves increases every four weeks, and each increase can temporarily worsen GI symptoms and electrolyte losses

Mushrooms have potassium and little sodium, which helps maintain good blood pressure

Research Evidence Comparison# Retatrutide Research# Phase 1 : First-in-human study established safety and pharmacokinetics Phase 2 (n=338) : Published in NEJM (2023), demonstrated dose-dependent weight loss up to 24.2% at 48 weeks with 12 mg dose